Good Products Accelerates Drug Development with Clinical Technology Consulting Services
Good Products launches the Clinical Technology Consulting division to facilitate biopharmaceutical sponsors' and CROs' use of clinical technology.
Nottingham, UK-June 12, 2008-Good Products, a leading provider of Enterprise Content Management (ECM) solutions for the pharmaceutical, biotechnology and medical device sectors has launched its new Clinical Technology Consulting division. Designed to enable biopharmaceutical sponsors and CROs to optimise their use of clinical technology, Good Products’ new consulting division combines over 100 years’ experience in the life sciences industry to offer remote and on-site expertise throughout North America and Europe.
Implementing and managing clinical technology can pose a variety of commercial and operational challenges for sponsors and CROs. Good Products’ new consulting services enable pharmaceutical organisations to maximize efficiency in their outsourced, in-house and hosted clinical technologies. These eClinical solutions include EDC, IVRS/IWRS, CTMS, ePRO, document management and digital signature solutions, as well as newly developed technologies including patient communication using cell phones.
eClinical technology experts in North America and Europe offer independent advice as to which solutions will work within companies’ individual structures and how technology should be implemented to increase efficiency and effectiveness within clinical research programmes. Additionally, Good Products offers guidance on deploying new technologies to complement existing workflows, and can advise on changing business strategy and working practices to increase the value of new and existing technologies.
Benefitting from expert consultants with a wealth of experience, operating companies and CROs can gain practical advice on areas such as data integration, optimising workflows, developing company-wide standards, auditing and reporting on clinical technology, choosing best-fit solutions and working with external vendors. The consulting division also offers assistance in formulating sales and marketing campaigns for clinical technology vendors looking to gain the edge in promoting their software and services.
Commenting on the launch of this new division of the company, Neil Rotherham, Executive Chairman of Good Products, stated; “I am delighted to announce the launch of this new eClinical Technology consulting division. We are offering sponsors and CROs with expertise enabling them to get the best out of the technology they already have or are looking to implement. Our range and depth of experience is unrivalled throughout the industry which means we are able to offer independent and practical advice based on vast experience in implementing software as a service and providing workflow consulting. This type of Clinical Technology Consulting represents an opportunity for clients to ensure that they get their technology installations right from day one and increase the value in these solutions through integration and workflow re-engineering.”
To coincide with the launch of this new service, Patrick Hughes, head of Good Products’ North American Clinical Technology Consulting Division, will take part in a discussion at the DIA Annual Meeting, June 22-26 2008, Boston, MA, USA. The presentation, entitled ‘Streamline Your Language Outsourcing [Best Practices for Centralizing Your Translations]’ will be held on Tuesday, June 24 at 8am in Room 205C.
For further information on the Good Products’ clinical trial consulting services, please visit
www.goodproductsEU.com
or email
[email protected]
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
